ArticleBMC health services research2025
Uptake, scale up, integration of caccine, immunization, and health supply chain management technologies and innovation into policy: experience from Tanzania.
Article in BMC health services research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe uptake, scale-up, and integration of technologies and innovations have been the emphasis of the government of Tanzania for sustained health systems strengthening. This study sought to assess the state and factors for the uptake, scale-up, and integration of Vaccine, Immunization, and Health Supply Chain Management (VIHSCM) technologies and innovations into policy, drawing on experiences from Tanzania.
methodsAn exploratory descriptive cross-sectional design with a mixed approach was conducted to assess associated factors for uptake, scale-up, and integration of VIHSCM technologies and innovative solutions for a wide coverage of the quality of vaccines. The data were collected from purposively and conveniently key informants from national, regional, district, and a health facility. A questionnaire was administered to 37 respondents at the health facility level and in-depth interviews were conducted with 104 key informants across all levels. Two Focus Group Discussions (FDGs) comprising 3 and 8 key informants were in one faith-based organization and a privately owned health facility respectively. An observational checklist and desk review were implemented to collect additional data and validation. As regards data analysis, qualitative data were thematically analyzed and quantitative data were analyzed descriptively using SPSS version 21.
resultsThe findings show that a range of innovations and technologies have been implemented for VIHSCM, with a primary focus on management and storage to guarantee consistent availability and caliber of vaccinations. Although the advantages of these technologies in improving availability and coverage are well acknowledged, the state of implementation indicates several challenges. Vaccine Information Management System (VIMS) has been put into practice at the council, regional, and national levels. Nevertheless, their efficacy is hampered by their continued fragmentation and lack of integration. Comparably, just 15 councils report that Tanzania Immunization Registry (TImR) has sufficient capability at the facility level. The potential influence of these technologies on VIHSCM is undermined by their incomplete scale-up and limited usefulness. Furthermore, the Remote Temperature Monitoring (RTM) tool, crucial for maintaining vaccine quality, is only operational up to the council level and suffers from inadequate integration. Consequently, many health facilities still rely on outdated methods like 30-day temperature loggers, which may compromise the integrity of temperature-sensitive vaccines.
conclusionThe value of technologies and innovations for improving VIHSCM is highly recognized for facilitating high-quality, effective, efficient, and equitable immunization services. However, the adopted technologies and innovations have been beneficial to only a small group of the population and for a short time because of inadequate scale-up and integration. Effective integration and scale-up of technologies and innovations are critical for a sustained effective VIHSCM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.